Marta Santisteban

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Hypertrophic Cardiomyopathy

Metastatic Breast Cancer

Regulatory T Cells

Top Venues

Therapeutic advances in medical oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, Jose-Luis Perez-Gracia, Javier Rodríguez Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio, Marta Santisteban
Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers 16 (5) (2024)
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, Jose-Luis Perez-Gracia, Javier Rodríguez Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio, Marta Santisteban
Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers 16 (5) (2024)
Luis Mejías-Sosa, Álvaro López-Janeiro, Alicia Córdoba Iturriagagoitia, Pablo Sala, Belen P Solans, Laura Hato, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Guillen-Grima, Jaime Espinós, Susana De La Cruz, María Dolores Lozano, Miguel A Idoate, Marta Santisteban
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. Biomedicines 11 (2) (2023)
Luis Mejías-Sosa, Álvaro López-Janeiro, Alicia Córdoba Iturriagagoitia, Pablo Sala, Belen P Solans, Laura Hato, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Guillen-Grima, Jaime Espinós, Susana De La Cruz, María Dolores Lozano, Miguel A Idoate, Marta Santisteban
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. Biomedicines 11 (2) (2023)
Luis Mejías-Sosa, Álvaro López-Janeiro, Alicia Córdoba Iturriagagoitia, Pablo Sala, Belen P Solans, Laura Hato, Susana Inogés, Ascensión López-Díaz de Cerio, Francisco Guillen-Grima, Jaime Espinós, Susana De La Cruz, María Dolores Lozano, Miguel A Idoate, Marta Santisteban
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies. Biomedicines 11 (2) (2023)
Borja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia, Naiara Perurena, Pablo Ruedas, Thomas Walle, Alberto Pezonaga-Torres, Juan Hinojosa, Elisabeth Guruceaga, Antonio Pineda-Lucena, Marta Abengózar-Muela, Denis Cochonneau, Carolina Zandueta, Susana Martínez-Canarias, Alvaro Teijeira, Daniel Ajona, Sergio Ortiz Espinosa, Xabier Morales, Carlos Ortiz de Solórzano, Marta Santisteban, Luis I Ramos-García, Laura Guembe, Vratislav Strnad, Dominique Heymann, Sandra Hervás-Stubbs, Ruben Pio, María E Rodríguez-Ruiz, Carlos E de Andrea, Silvestre Vincent, Ignacio Melero Bermejo, Fernando Lecanda, Rafael Martinez-Monge
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. Cancer discovery 12 (5) (2022)
Ana de la Fuente, Marta Santisteban, Josep Lupón, José Manuel Aramendía, Agnes Díaz, Ana Santaballa, Amparo Hernándiz, Pilar Sepúlveda, German Cediel, Begoña López, José María López Picazo, Manuel M Mazo, Gregorio Rábago, Juan José Gavira, Ignacio García-Bolao, Javier Díez, Arantxa González, Antoni Bayés-Genís, Susana Ravassa
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy. Cancers 14 (12) (2022)
Marta Santisteban, Belén Pérez Solans, Laura Hato, Amaia Urrizola, Luis Daniel Mejías, Esteban Salgado, Rodrigo Sánchez-Bayona, Estefanía Toledo, Natalia Rodríguez-Spiteri, Begoña Olartecoechea, Miguel Angel Idoate, Ascensión López-Díaz de Cerio, Susana Inogés
Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis. Therapeutic advances in medical oncology 13 (2021)
Patricia Martin-Romano, Iosune Baraibar, Jaime Espinós, Jairo Legaspi, Jose M López-Picazo, Jose Manuel Aramendía, Oscar A Fernández, Marta Santisteban
Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience. The breast journal 24 (4) (2017)